Long-term efficacy and safety of enzalutamide monotherapy in hormone-naïve prostate cancer: 2 –year follow-up

Bertrand Tombal, Michael Borre, Per Rathenborg, Patrick Werbrouck, Hendrik van Poppel, Axel Heidenreich, Peter Iversen, Johan Braeckman, Jiri Heracek

Original languageEnglish
Article numberPD766
JournalAnnals of oncology : official journal of the European Society for Medical Oncology / ESMO
Volume25
Issue number4
ISSN0923-7534
Publication statusPublished - 2014

Cite this